Patents Assigned to Resolution Pharmaceutical Inc.
  • Hydrazino-type N.sub.2 S.sub.2 chelators
    Patent number: 5574140
    Abstract: Radionuclide chelating compounds are provided for conjugation to targetting molecules such as proteins, peptides or antibodies. The resulting labelled targetting molecules may be used in diagnosis and therapy.
    Type: Grant
    Filed: July 14, 1994
    Date of Patent: November 12, 1996
    Assignee: Resolution Pharmaceutical Inc.
    Inventors: Alfred Pollack, Robert A. Kirby, Robert Dufault